LV10917B - New use of bambuterol - Google Patents

New use of bambuterol Download PDF

Info

Publication number
LV10917B
LV10917B LVP-93-816A LV930816A LV10917B LV 10917 B LV10917 B LV 10917B LV 930816 A LV930816 A LV 930816A LV 10917 B LV10917 B LV 10917B
Authority
LV
Latvia
Prior art keywords
bambuterine
lipid
lowering
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
LVP-93-816A
Other languages
English (en)
Latvian (lv)
Other versions
LV10917A (lv
Inventor
Bauer Carl-Axel
Svensson Leif-Ake
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10917A publication Critical patent/LV10917A/xx
Publication of LV10917B publication Critical patent/LV10917B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LVP-93-816A 1990-03-16 1993-06-30 New use of bambuterol LV10917B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use
PCT/SE1991/000195 WO1991013615A1 (en) 1990-03-16 1991-03-14 New use of bambuterol

Publications (2)

Publication Number Publication Date
LV10917A LV10917A (lv) 1995-12-20
LV10917B true LV10917B (en) 1996-04-20

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-816A LV10917B (en) 1990-03-16 1993-06-30 New use of bambuterol

Country Status (28)

Country Link
US (2) US5837727A (ru)
EP (1) EP0521967B1 (ru)
JP (1) JP3081640B2 (ru)
KR (1) KR100194995B1 (ru)
AT (1) ATE138570T1 (ru)
AU (1) AU653149B2 (ru)
CA (1) CA2077762C (ru)
CZ (1) CZ279308B6 (ru)
DE (1) DE69119896T2 (ru)
DK (1) DK0521967T3 (ru)
EG (1) EG19645A (ru)
ES (1) ES2087291T3 (ru)
GR (1) GR3020700T3 (ru)
HK (1) HK52197A (ru)
HU (1) HU211998B (ru)
IE (1) IE80668B1 (ru)
IL (1) IL97509A (ru)
LT (1) LT3734B (ru)
LV (1) LV10917B (ru)
MY (1) MY114218A (ru)
NZ (1) NZ237279A (ru)
PT (1) PT97052B (ru)
RU (1) RU2093153C1 (ru)
SE (1) SE9000948D0 (ru)
SG (1) SG64895A1 (ru)
SK (1) SK278815B6 (ru)
WO (1) WO1991013615A1 (ru)
ZA (1) ZA911452B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
IL162270A0 (en) 2001-12-14 2005-11-20 Novo Nordisk As Compounds and uses thereof for decreasing activityof hormone-sensitive lipase
ES2312669T3 (es) * 2002-08-08 2009-03-01 Wen Tan R-bambuterol, su preparacion y usos terapeuticos.
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7689T1 (de) * 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Also Published As

Publication number Publication date
CA2077762C (en) 2001-06-12
LTIP1735A (en) 1995-07-25
US5837727A (en) 1998-11-17
RU2093153C1 (ru) 1997-10-20
EP0521967A1 (en) 1993-01-13
KR100194995B1 (ko) 1999-06-15
EP0521967B1 (en) 1996-05-29
CA2077762A1 (en) 1991-09-17
PT97052B (pt) 1998-07-31
MY114218A (en) 2002-09-30
HK52197A (en) 1997-05-02
IE910862A1 (en) 1991-09-25
WO1991013615A1 (en) 1991-09-19
DE69119896T2 (de) 1996-10-10
HU9202958D0 (en) 1992-12-28
LT3734B (en) 1996-02-26
CZ279308B6 (cs) 1995-04-12
IL97509A (en) 1995-12-31
DK0521967T3 (da) 1996-09-09
AU653149B2 (en) 1994-09-22
JP3081640B2 (ja) 2000-08-28
IE80668B1 (en) 1998-11-18
EG19645A (en) 1995-09-30
GR3020700T3 (en) 1996-10-31
ATE138570T1 (de) 1996-06-15
US6034123A (en) 2000-03-07
HU211998B (en) 1996-01-29
SK278815B6 (sk) 1998-03-04
DE69119896D1 (de) 1996-07-04
CS9100681A2 (en) 1991-10-15
SG64895A1 (en) 2000-01-25
AU7569191A (en) 1991-10-10
HUT61461A (en) 1993-01-28
ZA911452B (en) 1991-11-27
NZ237279A (en) 1993-08-26
SE9000948D0 (sv) 1990-03-16
PT97052A (pt) 1991-10-31
ES2087291T3 (es) 1996-07-16
LV10917A (lv) 1995-12-20
IL97509A0 (en) 1992-06-21
JPH05504971A (ja) 1993-07-29

Similar Documents

Publication Publication Date Title
AU2000249434B2 (en) Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
PL323487A1 (en) Three-phase pharmaceutic form of constant-rate controllable release of amorphous active ingredient for administration once per day
JP2004501121A5 (ru)
NO872259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive trans-6(2-(3-eller 4-karboksamido-substituert-pyrrol-1-yl)alkyl)-4-hydroksypyran-2-on-derivater.
TNSN90003A1 (fr) Derives de 2-aminopyrimidinones utiles notamment comme antagonistes des neurotransmetteurs et procede pour leur preparation
AU2000249434A1 (en) Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
IE782070L (en) Azabicyclo (3.2.0) hept-2-ene carboxylic acid derivatives
LV10917B (en) New use of bambuterol
DE19975059I2 (de) (2-Oxo-3-tetrahydrothienylcarbamoyl)-alkylthio-essigsäure, ihre Salze und Ester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel.
IL95956A0 (en) Benzoic acid derivatives and pharmaceutical compositions containing the same
AU8268591A (en) Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions
CA2344053A1 (en) Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases
AU3003189A (en) 7(2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetamido)-3- methoxymethyl-3-cephem-4-carboxylate ester derivatives
IL70560A0 (en) Dialkylaminoalkoxybenzyl alcohol derivatives,their preparation and pharmaceutical compositions containing them
ATE27270T1 (de) Thioester von acetylsalicylsaeure, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0347902A3 (en) Pyrrolecarboxylic acid derivatives
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
CA2310318A1 (en) Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
ATE1855T1 (de) Antiarthritische hydroxyessigsaeurederivate, pharmazeutische zusammensetzungen daraus und verfahren zu ihrer herstellung.
IE41219B1 (en) Aralkyl esters of aminoalkanoic acids
AU668398B2 (en) New aminoalkylchromones, processes for the preparation thereof, and pharmaceutical compositions containing them
AU588960B2 (en) New nitrogen-arylmethoxy-thiophene derivatives and acid addition salts thereof, processes for their preparation and pharmaceutical preparations containing these compounds
WO1987004435A3 (en) Xanthine compounds
IT1265108B1 (it) Amidi di acidi biliari, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
Tanabe et al. Characterization and structural study of inclusion compounds of α-keto acids with cyclodextrins